Literature DB >> 26413220

Innate immune recognition of hepatitis B virus.

Hong-Yan Liu1, Xiao-Yong Zhang1.   

Abstract

Hepatitis B virus (HBV) is a hepatotropic DNA virus and its infection results in acute or chronic hepatitis. It is reported that the host innate immune system contributes to viral control and liver pathology, while whether and how HBV can trigger the components of innate immunity remains controversial. In recent years, the data accumulated from HBV-infected patients, cellular and animal models have challenged the concept of a stealth virus for HBV infection. This editorial focuses on the current findings about the innate immune recognition to HBV. Such evaluation could help us to understand HBV immunopathogenesis and develop novel immune therapeutic strategies to combat HBV infection.

Entities:  

Keywords:  Hepatitis B virus; Hepatocytes; Innate immunity; Interferon; Pathogen-recognition receptor

Year:  2015        PMID: 26413220      PMCID: PMC4577638          DOI: 10.4254/wjh.v7.i21.2319

Source DB:  PubMed          Journal:  World J Hepatol


  27 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 3.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

4.  Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

Authors:  Xiaoyong Zhang; Anke Kraft; Ruth Broering; Joerg F Schlaak; Ulf Dittmer; Mengji Lu
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

5.  GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees.

Authors:  Robert E Lanford; Bernadette Guerra; Deborah Chavez; Luis Giavedoni; Vida L Hodara; Kathleen M Brasky; Abigail Fosdick; Christian R Frey; Jim Zheng; Grushenka Wolfgang; Randall L Halcomb; Daniel B Tumas
Journal:  Gastroenterology       Date:  2013-02-13       Impact factor: 22.682

Review 6.  HBV and the immune response.

Authors:  Carlo Ferrari
Journal:  Liver Int       Date:  2015-01       Impact factor: 5.828

7.  Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Authors:  Stephan Menne; Daniel B Tumas; Katherine H Liu; Linta Thampi; Dalal AlDeghaither; Betty H Baldwin; Christine A Bellezza; Paul J Cote; Jim Zheng; Randall Halcomb; Abigail Fosdick; Simon P Fletcher; Stephane Daffis; Li Li; Peng Yue; Grushenka H I Wolfgang; Bud C Tennant
Journal:  J Hepatol       Date:  2015-01-02       Impact factor: 25.083

8.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Authors:  Clifford S Guy; Patricia M Mulrooney-Cousins; Norma D Churchill; Tomasz I Michalak
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

10.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

View more
  3 in total

1.  Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro.

Authors:  Sergey Brezgin; Anastasiia Kostyusheva; Ekaterina Bayurova; Ilya Gordeychuk; Maria Isaguliants; Irina Goptar; Anastasiia Nikiforova; Valery Smirnov; Elena Volchkova; Dieter Glebe; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Microorganisms       Date:  2019-11-06

2.  Chronic hepatitis B virus and liver fibrosis: A mathematical model.

Authors:  Avner Friedman; Nourridine Siewe
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

Review 3.  Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure.

Authors:  Anastasiya Kostyusheva; Dmitry Kostyushev; Sergey Brezgin; Elena Volchkova; Vladimir Chulanov
Journal:  Genes (Basel)       Date:  2018-10-05       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.